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ischemia/reperfusion injury were markedly protected againstMeprin, a brush-border enzyme, plays an important role in
acute renal failure by IP treatment with actinonin.hypoxic/ischemic acute renal tubular injury in rats.
Conclusions. Meprin is cytotoxic to cultured renal tubularBackground. It has been shown that non-congenic mice
epithelial cells in vitro. Renal slices are protected from hypoxia-strains with lower levels of renal meprin develop less renal
reoxygenation injury in vitro by the meprin inhibitor actinonin.injury following renal ischemia and reperfusion. We have dem-
onstrated that following ischemia-reperfusion renal injury, Meprin inhibition is protective against rat renal hypoxia-reoxy-
there is a rapid shift of meprin localization and intensity from genation injury. These data strongly support the concept that
the brush border to the cytoplasmic compartment, tubular lu- meprin is cytotoxic and may play a key role in renal ischemia-
mens and the tubular basement membranes. Radical shifts in reperfusion induced renal injury.
the localization of an activated enzyme to potentially sensitive
areas of the tubule suggest a toxic role for meprin in ischemia-
reperfusion injury. Though meprin degrades extracellular ma-
Significant advances in the understanding of the celltrix components and other substrates, to our knowledge meprin
cytotoxicity has never been examined. Therefore, the first ob- biology of ischemic acute renal failure have occurred
jective of this study was to determine if meprin is directly and the interrelationships between many of the major
cytotoxic to renal cells in vitro. The second objective was to
processes underlying the cellular changes in renal tubulesdetermine if inhibition of meprin is protective against hypoxia-
following ischemia-reperfusion injury are being definedreoxygenation injury in vitro and ischemia-reperfusion injury
in vivo. [1–3]. Nonetheless, the form of acute renal failure tradi-
Methods. The immortalized porcine epithelial cell line (LLC- tionally referred to as acute tubular necrosis (ATN) re-
PK1) and Madin-Darby canine kidney (MDCK) cells in culture mains common, and continues to be associated with awere exposed to meprin in various concentrations and for vari-
very high mortality unchanged since hemodialysis be-ous times. Cell death was determined by Trypan Blue exclu-
sion, lactate dehydrogenase (LDH) release and the 3-[4,5] di- came widely available some 30 years ago. Renal ischemia
methylthiazol-2,5-diphenyltetrazolium bromide (MTT) assay. initiates a complex cascade of intra- and extracellular
Renal slices were used to examine the effect of the meprin renal tubular events, some reversible and some irrevers-
inhibitor, actinonin, on hypoxic injury in vitro. Male Sprague-
ible, and results in acute renal failure [reviewed in 4–8].Dawley rats were used in ischemia-reperfusion injury studies
Elucidation of these pathways, particularly the early trig-to determine the effect of actinonin on renal function as mea-
sured by plasma urea nitrogen, creatinine and renal histology. gering mechanisms, is critically important for the ulti-
Results. Meprin is cytotoxic to LLC-PK1 and MDCK cells mate understanding and eventual intervention in this
in a concentration and time dependent manner. The meprin
potentially lethal condition.inhibitor 1,10-phenanthroline completely abolished the cyto-
We demonstrated alterations in extracellular matrixtoxic effect. Renal slices exposed to hypoxia and hypoxia fol-
lowed by reoxygenation showed marked cell death. Pre-treat- components following ischemia-reperfusion injury [9]
ment with the actinonin was markedly protective while not and this led us to search for the matrix degrading en-
interfering with the hypoxia-induced fall in adenosine 5-tri- zyme(s) important in these alterations. We subsequentlyphosphate (ATP) levels. In in vivo studies, rats exposed to
showed that meprin is the major matrix-degrading en-
zyme in rat renal tubules [10, 11], and this prompted the
1 See Editorial by Baricos, p. 1174. hunt for a role for meprin in renal ischemia-reperfusion
injury. Recently, we observed a prominent redistributionKey words: renal failure, cytoxicity, ischemia/reperfusion injury, acute
tubular necrosis, reoxygenation, hypoxia, extracellular matrix. of meprin from its usual brush border locale to intracy-
toplasmic, luminal and extracellular matrix locations
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failure compared to those with normal meprin levels peared as a single band at 85 kD on sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE)when exposed to ischemia-reperfusion [13].
Early studies of ischemia-reperfusion–induced acute under reducing conditions and was capable of degrading
extracellular matrix components [10, 12].renal failure demonstrated a rapid (within minutes)
sloughing of brush border into the tubular lumens and/or
Cell cultureuptake of brush border into the cytoplasm [14, 15] consis-
tent with our demonstration of meprin in the cytoplasm LLC-PK1 and MDCK cells were maintained in 75 cm2
culture flasks with Dulbecco’s modified Eagle’s mediumand in tubular lumens [12]. Taken together, these obser-
vations suggested the possibility of direct cytotoxic ef- (DMEM) supplemented with 10% fetal bovine serum
(FBS), 1% l-glutamine, Fe(NO3)3 (0.1 mg/liter) and non-fects of meprin on renal tubular epithelial cells that has
not been previously demonstrated. Thus, the first objec- essential amino acids at 37C in a 5% CO2-95% air atmo-
sphere. Subculture of confluent monolayers was carriedtive of this study was to determine if meprin is directly
cytotoxic to renal cells in vitro. The second objective out using 0.05% trypsin, 0.53 mmol/L ethylenediamine-
tetraacetic acid (EDTA) in calcium and magnesium-freewas to determine if inhibition of meprin is protective
against hypoxia-reoxygenation injury in vitro and isch- Hanks balanced salt solution (HBSS). Prominent dome
formation was seen at two days post-confluence by phaseemia-reperfusion injury in vivo.
contrast microscopy [16]. For the 3-[4,5-dimethlythiazol-
2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assay,
METHODS
cells were plated in 96 well microplates at 2105 cells/
Materials well. After six hours, the medium was gently changed
to remove non-adherent cells. The plates were then usedSepharose, concanavalin A-Sepharose, gelatin Sepha-
rose, Sephadex G-200, Sephacryl S-300, soybean trypsin for assays after 24 hours.
inhibitor, pepstatin, leupeptin, phenylmethylsulfonyl fluo-
Cell viability determinationride (PMSF), bovine serum albumin (BSA), Triton X-100,
NP-40, molecular weight standards and all other reagents Cell viability was analyzed using Trypan Blue exclu-
sion [16, 17], LDH release [18, 19] and the MTT assayand chemicals not otherwise specified were obtained from
Sigma Chemical Co. (St. Louis, MO, USA). Hydroxylapa- [20, 21]. Trypan blue was determined as in our previous
studies [16, 17]. Cells failing to exclude the dye weretite and all materials for gel electrophoresis were obtained
from Bio-Rad Labs (Richmond, CA, USA). DEAE-cellu- considered non-viable and the data expressed as a per-
centage of the total. LDH release was measured by thelose (DE-52) was obtained from Whatman Chemical Sepa-
rations, Ltd. (Hillsboro, OR, USA). LLC-PK1 and MDCK method of Bergmeyer [22] as in our previous studies
[18]. Samples of 300 L of incubation medium and 300cells were obtained from the American-Type Culture
Collection (Rockville, MD, USA) and were used in less L of cell suspension were solubilized with 60 L of 2%
Triton X and analyzed for LDH. Results were presentedthan 15 passages from the seed stock. All tissue and
organ culture materials were obtained from Gibco BRL as % of LDH release in the medium compared with total
LDH (medium  cell suspension). The MTT assay was(Grand Island, NY, USA). Male Sprague-Dawley rats
(250 to 300 g) were obtained from Harlan Sprague-Daw- carried out on cells in 96 well plates. After exposure to
meprin, the medium was removed, the monolayer gentlyley Inc. (Indianapolis, IN, USA). The rats were cared
for in accord with the NIH guidelines for the care and washed in serum free DMEM and 200 L of MTT (1
mg/mL in HBSS) was added to each well and incubateduse of laboratory animals in a federally approved vivar-
ium. The rat quarters were kept at constant room tem- for one hour. The medium was replaced with 100 L of
2-isopropanol for 20 minutes and the absorbance at 540perature with 12-hour day/night cycles and the rats had
free access to standard rat chow and water. nm was determined using a microplate reader (Molecu-
lar Devices Corp., Palo Alto, CA, USA). Each group
Renal cortical meprin A purification consisted of 6 wells and the experiment was carried out
three times.Rat renal cortical meprin A was purified from the
renal cortices of 125 male Sprague-Dawley rats as in our
Cell treatmentprevious studies [10, 12]. Briefly, the renal cortices were
rapidly homogenized in 50 mmol/L Tris-HCl buffer, pH LLC-PK1 cells were treated with purified meprin (0,
2, 3, 4 5, 6, 7, or 8 g per mL) for 10, 20, 30, and 607.5 containing PMSF, leupeptin and pepstatin, and the
membrane fraction was obtained by ultracentrifugation minutes and cell viability determined by LDH. Based
on these experiments, optimum time of meprin exposureat 100,000  g. Extracellular matrix degrading activity
was purified through a series of columns including DE-52, was set at 60 minutes for all remaining studies. The effect
of meprin on cell viability was determined using LLC-hydroxylapatite, concanavalin A-sepharose and gelatin-
sepharose. The purified enzyme was homogeneous, ap- PK1 and MDCK cells. Meprin was added in various
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concentrations (0, 2, 3, 4, 5, 6, and 8 g) and cell death ATP content
was measured by LDH release and the MTT assay. To The ATP content of renal slices was determined using
demonstrate that meprin-induced cell death was due to the luciferin-luciferase assay (Sigma) as previously de-
its enzyme activity, the effect of meprin inhibition by scribed [27]. At the end of an experimental maneuver,
increasing concentrations of 1,10-phenantroline (0, 2, 10, slices were blotted; placed in 1 mL 10% trichloroacetic
20, 40 mmol/L) was examined using LLC-PK1 cells ex- acid, homogenized, snap frozen in liquid nitrogen, and
posed to meprin (6 g/mL) with cell viability measured
stored at –70C until analyzed. The homogenates wereby LDH release.
thawed, centrifuged at 10,000  g for five minutes and
the supernatant diluted in 2 mL HEPES buffer. TwoCell attachment assay
hundred microliters of sample were added to 100 L ofFollowing exposure to increasing concentrations of
luciferin-luciferase solution (5 mg/mL) in a Turner TD-20emeprin (0, 2, 4, 6, and 8 g/mL), the cell culture medium
luminometer (Turner Designs, Sunnyvale, CA, USA).was removed and the cells in the medium counted with
The ATP content is expressed relative to the proteina hemocytometer using a light microscope [23]. The cells
content determined using the Bio-Rad Protein Assay.released into the supernatant were expressed as cells/mL.
Renal slices Matrix degrading activity
Male Sprague-Dawley rats (250 to 300 g) were anes- Renal matrix degrading activity was measured using
thetized with Nembutal and the kidneys rapidly removed radiolabeled gelatin as in our previous study [10, 11].
and placed in the tissue holder of the Vitron Slice instru- Briefly, [3H]-gelatin (30,000 cpm) was incubated with
ment (Vitron Inc., Tucson, AZ, USA) containing ice- tissue homogenate for one hour at 37C and the reaction
cold DMEM-Ham’s nutrient medium [24]. The renal stopped with 50% trichloroacetic acid (TCA). The non-
slices (about 250 m thick, weighing 20 to 25 mg) were TCA-precipitable supernatant was counted in a liquid
floated off the blade and collected into Weymouths’ me- scintillation counter.
dium for all experiments. The slices were placed on stain-
less steel titanium mesh cylinders and enclosed in glass Ischemia-reperfusion model
scintillation vials containing 1.6 mL of Weymouths’ me- This model was induced essentially as in our previous
dium and incubated in a dynamic organ culture system
studies [9, 12]. Male Sprague-Dawley rats (250 to 300 g)(Vitron incubator). This volume wets but does not sub-
were rested from travel for no less than five days beforemerge the slice. The vials were gassed with 95%O2/5% experiments were initiated. The rats were anesthetizedCO2 and placed in the rotating incubator at 3 RPM. This
with Nembutal, placed on a warming pad under a heatingallows the slice to rotate into and out of the nutrient
lamp, and an incision through the linea alba was made.medium, permitting aeration and nutrient-waste ex-
Both kidneys were isolated, decapsulated and external-change. As in previous studies [25, 26], slices were al-
ized. Arterial clamps were used to occlude both renallowed to recover for two hours prior to experimental
pedicles for 40 minutes under sterile conditions. Follow-protocol induction.
ing clamp release, the incisions were closed and the ani-The use of slices produced with the Vitron tissue appa-
mals were allowed to recover before being returned toratus provides a significant advantage over those made
with the Stadie-Riggs system. Vitron slices are more their cages. Some rats received actinonin IP 45 minutes
uniform and much thinner than Stadie-Riggs slices, pro- prior to surgery, after renal artery clamp release and two
viding superior gas and metabolite exchange. Also, the hours later. Controls received equal volumes of saline
control renal slices did not undergo central necrosis in IP. After reperfusion for 24, 72 and 144 hours, the ani-
the time frames examined, which is often the case with mals were anesthetized, blood was drawn for plasma
Stadie-Riggs slices. urea nitrogen and creatinine followed by exsanguination
and the kidneys removed for histology.Hypoxia and re-oxygenation
Hypoxic conditions were induced by placing the slices Histology
in covered vessels containing Weymouths’ medium pre-
The kidneys were sectioned, fixed in formalin, dehy-viously gassed with N2/CO2 (PO2 50%) [26]. After two drated and embedded in paraffin. Sections (3 m) werehours recovery, slices were exposed to hypoxia for two
stained with hematoxylin and eosin or periodic acid-hours, and then re-oxygenated for two hours. In some
Schiff reagent, coded and examined without knowledgeexperiments, the meprin inhibitor actinonin (5 g/mL)
of the treatment protocol. A semiquantitative analysiswas added to hypoxia medium. Injury measured as cell
was carried out as in our previous studies [9, 12]. Briefly,death by LDH release, was analyzed before incubation,
the changes were graded as follows: 0  normal; 1 after the two-hour recovery, after two hours of hypoxia,
areas of tubular epithelial cell swelling, desquamation,and after two hours of hypoxia and two hours of reperfu-
sion. brush border loss and necrosis involving less than 5%
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Fig. 1. Meprin causes cell death in LLC-PK1 and MDCK cells. (A)
Representative experiment demonstrating that increasing time expo-
sure to meprin and increasing concentrations of meprin causes increas-
ing cell death. (One representative experiment of three shown using
LLC-PK1 cells and the LDH assay). Exposure times utilized in the
experiment were: 10 (), 20 (), 30 () and 60 minutes (). The
results are expressed as % of LDH released. (B) LLC-PK1 () and
MDCK () cells died when exposed to increasing concentrations of
meprin (varying concentrations of meprin after 60 min). N  3, *P 
0.001 at 4 g/mL compared to control. The results are expressed as %
of LDH released. (C ) LLC-PK1 () and MDCK () cells died when
exposed to increasing concentrations of meprin (MTT assay, varying
concentrations of meprin after 60 min. N  3, *P  0.001 at 4 g/mL
compared to control for LLC-PK1 cells, **P  0.001 at 7 g/mL com-
pared to control for MDCK cells).
of the corticomedullary tubules; 2  similar changes cytotoxicity. An initial time course and dose response
study was carried out using LLC-PK1 cells and LDHinvolving 5% but 50% of the corticomedullary tu-
bules; 3  similar changes involving 50% of the corti- assay to measure cell viability. We observed that a me-
comedullary tubules but uninvolved tubules easily found; prin concentration of 4 g/mL incubated for 20 minutes
4  similar changes involving all or almost all of the induced almost 50% LDH release. With increased con-
corticomedullary tubules. centrations of meprin (5 and 8 g/mL) and increased
time of exposure (60 min), there was approximately 75%
Statistical analysis LDH release. The results of one experiment (representa-
The results are expressed as the mean 	 SEM. All tive of three) are shown (Fig. 1A). The remaining experi-
experiments were carried out at least in triplicate cell ments were carried out using 60 minutes of exposure to
or slice preparations and compared using analysis of meprin. A meprin dose response was carried out for both
variance (ANOVA) with post hoc testing for significance LLC-PK1 and MDCK cells using Trypan Blue exclusion,
at P  0.05 (StatView 4.5) on a Macintosh G4-450 Com- LDH release and the MTT assay. There was a concentra-
puter (Apple Computer, Cupertino, CA, USA). tion dependent increase in cell death for both LLC-
PK1 and MDCK cells as determined by Trypan Blue
exclusion (data not shown), the LDH assay (Fig. 1B)RESULTS
and MTT assay (Fig. 1C). A dose response study was
Meprin causes cell death done using the meprin inhibitor 1,10-Phenanthroline on
LLC-PK1 cells. Cell viability was analyzed by LDH assay.Though meprin has been shown to degrade various
proteins [10, 28–30], it has not been examined for direct There was a significant decrease in meprin-induced cell
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Table 1. Meprin does not increase cultured cell release
into the medium
Meprin lg/mL
Time minutes 0 2 4 6 8
0 2.2	0.2 3.0	0.3 2.6	0.2 3.4	0.3 2.4	0.3
10 3.5	0.2 5.1	0.4 4.7	0.3 2.1	0.2 2.5	0.3
20 4.1	0.4 4.5	0.2 4.1	0.4 2.9	0.4 5.2	0.4
30 1.8	0.3 3.8	0.3 4.3	0.3 2.4	0.3 4.3	0.2
60 1.9	0.2 3.8	0.2 3.8	0.4 3.4	0.1 3.9	0.2
LLC-PK1 cells were incubated with or without meprin for various times and
in various concentrations. No increase in released cells was seen. P  not signifi-
cant, N  4.
death with increasing concentrations of 1,10-phenan-
throline (data not shown). To demonstrate that phenan-
throline did not interfere with the assays, similar concen-
trations of phenanthroline were added at the end of the
experiment with no effect on either trypan blue exclu-
sion, LDH release or the MTT assay (data not shown).
Meprin does not increase cell detachment
Cell sloughing is a prominent feature of acute tubular
necrosis [31], and given our previous studies demonstra-
ting release of meprin into the tubular lumen and along
the tubular basement membrane [12], we considered the
possibility that meprin might enhance cell detachment
in renal epithelial cells in culture. Thus, as part of the Fig. 2. Actinonin (5 g/mL) protects against hypoxia and hypoxia-
reoxygenation–induced cell death in renal slices as determined by lac-cytotoxicity studies, we examined the number of cells
tate dehydrogenase (LDH) release. Abbreviations are: H, hypoxia; R,
released into the culture medium. There were no changes reperfusion; Act, actinonin. N  4 to 6; *P  0.0001 compared to
comparable group without actinonin.in the number of cells released into the medium when
LLC-PK1 cells were exposed to increasing meprin con-
centration and incubation time (Table 1). Meprin also
of slices with actinonin during hypoxia was significantlydid not cause an increase in MDCK cells released into
protective against injury. Cell death induced by hypoxiathe medium.
followed by re-oxygenation also was markedly reduced
in slices incubated with actinonin. Minimal LDH releaseRenal slices are protected from hypoxia-reoxygenation
was seen in slices immediately after preparation and ininjury in vitro by the meprin inhibitor actinonin
slices rested for two hours (Fig. 2).
To examine the role of meprin in renal hypoxia-reoxy- To determine if actinonin interfered with the fall in
genation injury in vitro, we used renal slices [32]. This ATP induced by hypoxia, we measured total slice ATP
in vitro technique was chosen over cell culture because content (Table 2). Following two hours of hypoxia, there
available renal cell lines do not express meprin (LLC- was a marked reduction in renal slice ATP content with
or without the addition of actinonin. Actinonin did notPK1, MDCK, OK, BSC-1 and RTE cells tested using
interfere with the changes in ATP content after twoWestern blot and activity assays, data not shown).
hours of hypoxia and two hours of reperfusion. To dem-In preliminary studies, actinonin was shown to inhibit
onstrate that actinonin did not interfere with the LDHslice meprin activity in a concentration dependent man-
assay, similar concentrations of actinonin were added atner. Incubation of renal slices for 45 minutes produced
the end of the experiment with no effect on LDH releasean almost complete loss of meprin activity with minimal
(data not shown).
recovery at eight hours.
Actinonin (5 g/mL) provided marked protection Actinonin is protective against ischemia-reperfusion
injury in ratsagainst hypoxia/re-oxygenation induced cell death when
LDH was analyzed (Fig. 2). Slices exposed to hypoxia The effects of the meprin inhibitor actinonin on renal
function were examined in rats exposed to 40 minutesdemonstrated marked cell death, however the incubation
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Table 3. Actinonin is protective in rat renal ischemia-reperfusionTable 2. Actinonin did not interfere with the fall
in ATP induced by hypoxia injury as determined by histology
Reperfusion hours Ischemia Ischemia & actinoninATP content
% control
24 3.75	0.3 2.60	0.6
72 1.80	0.3 1.00	0.0Time zero 100	2
2 Hour recovery 94	3 144 1.25	0.3 0.75	0.3
2 Hours hypoxia 50	6a Rat kidneys exposed to ischemia followed by 24, 72 and 144 hours reperfusion
2 Hours hypoxia  actinonin 53	6a with or without actinonin, were examined histologically. A semiquantitative
2 Hours hypoxia  2 Hours reperfusion 53	3a analysis was carried out and the injury was graded as follows: 0  normal; 1 
2 Hours hypoxia  2 Hours reperfusion  actinonin 59	3a areas of tubular epithelial cell swelling, desquamation, brush border loss and
necrosis involving less than 5% of the cortico-medullary tubules; 2  similar6 Hours control 88	3
changes involving 5% but 50% of the cortico-medullary tubules; 3  similar6 Hours control  actinonin 91	3
changes involving50% of the cortico-medullary tubules but uninvolved tubules
Renal slices were incubated with or without actinonin (5 g/mL) and ATP easily found; 4  similar changes involving all or almost all of the cortico-
content was determined by the luciferin-luciferase assay. medullary tubules. The data are expressed as mean 	 SEM, N  4–5.
a P  0.001 compared to 2 hour recovery, N  4
Fig. 3. Actinonin protects against ischemia-reperfusion–induced renal failure as determined by plasma urea nitrogen and plasma creatinine. The
rats were exposed to ischemia by bilateral clamping of the renal pedicle followed by reperfusion. Some rats received actinonin 1.25 mg/100 g body
weight () first given IP 45 minutes prior to surgery, then immediately after renal artery clamp release and a final injection 2 hours after the
ischemic insult. Control and sham animals () received equal volumes of saline IP using the same injection schedule. At the end of reperfusion
(24, 72 and 144 h) the rats were sacrificed, blood collected and creatinine (A) and BUN (B) analyzed. (N  4-5, *P  0.05).
of ischemia followed by 24, 72 and 144 hours of reperfu- experienced a marked protection of renal function, with
plasma creatinine and BUN concentrations approxi-sion. In preliminary studies, we established that meprin
activity is completely inhibited for three hours by acti- mately 70% lower after the first 24 hours. At 72 hours
the levels were about 50% of control, and the renalnonin 1.25 mg/100 g body wt administered IP. Thus,
actinonin was first given an IP injection 45 minutes prior function in both groups had almost completely recovered
by six days (144 hours). Semiquantitative analysis ofto surgery, then immediately after renal artery clamp
release, and a final injection two hours after the ischemic histologic sections of kidneys after ischemia-reperfusion
injury with or without actinonin treatment was carriedinsult. Control and sham animals received equal volumes
of saline IP using the same injection schedule. We also out and the results are shown in Table 3. Histologic
changes following ischemia-reperfusion injury were simi-showed that in animals subjected to 40 minutes of isch-
emia without actinonin, total renal cortical matrix de- lar to those seen in our previous studies [9, 12]. In rats
exposed to ischemia-reperfusion injury alone, there wasgrading activity remained unchanged over the first 12
hours following ischemia. marked epithelial cell necrosis with sloughing at 24
hours. Most of the corticomedullary tubules were in-Treatment with actinonin markedly protected against
a fall in renal function (Fig. 3). In the control animals, volved. However, in actinonin treated rats, there was a
prominent decrease in the amount of histologic injurythere was a significant increase in BUN and creatinine
after 24 hours, at 72 hours the levels dropped to about at 24 hours. This protective effect continues throughout
the study period with actinonin treated animals showinghalf of the levels reached in 24 hours, and at 144 hours
they were almost normal. Rats treated with actinonin less injury at every time point (Table 3).
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DISCUSSION meprin than other members of this enzyme group. For
example, actinonin is about 1000 times more activeThe genetics, structure and cellular location of meprin
against meprin than against astacin itself [36]. Actinoninhave been well described [reviewed in 33]. Previous stud-
also has much greater inhibitory activity against meprinies have also focused on the ability of meprin to degrade
than against aminopeptidase N [37]. Given that meprin isvarious substrates including: protein kinase A [34], extra-
the major matrix degrading enzyme in the kidney [10–12]cellular matrix components gelatin, collagen I and IV,
and that actinonin is highly specific as an inhibitor of me-laminin, fibronectin [10, 30], and nidogen [12], bradykinin,
prin, we next examined the effect of actinonin on meprinalpha-melanocyte stimulating hormone (MSH), neuro-
activity and its effect in renal hypoxia-reoxygenation in-tensin, luteinizing hormone releasing hormone (LHRH),
jury in vitro and ischemia-reperfusion injury in vivo.angiotensin I, angiotensin II [28, 30], and parathyroid hor-
Renal slices were required for the in vitro studies duemone [29]. Despite extensive investigation of meprin A
to the lack of meprin expression in renal tubular celland especially considering its limited substrate specific-
primary cultures and available renal cell lines (LLC-PK1,ity, there was little to suggest that meprin would be cyto-
MDCK, OK, BSC-1, and RTE). Renal slices have beentoxic and in fact, no previous studies investigating meprin
previously used to examine meprin biosynthesis and deg-as a cytotoxic agent have been reported. Our previous
radation [32]. In addition, renal slices have been usedstudy demonstrating meprin redistribution following
previously in hypoxia-reoxygenation studies [26]. Inischemia-reperfusion injury in vivo suggested a potential
these studies, actinonin (5 g/mL) was markedly protec-role for meprin in direct cell death [12]. Particularly
tive against cell death as measured by LDH release. Theimportant was the observation that meprin accumulates
protection against renal tubular cell hypoxia-reoxygena-in the renal tubules downstream from its normal location.
tion injury by actinonin was not due to an effect on ATPThese observations suggest that if meprin were to be
content in that it did not interfere with the fall in ATPcytotoxic, addition of meprin to the surface of cells in
induced by hypoxia. In in vivo experiments, actinoninculture could lead to cell death [12]. Thus, the first objec-
was markedly protective against a fall in renal function
tive of this study was to evaluate the cytotoxic effect of
induced by ischemia-reperfusion injury in rats. It did not
meprin on renal tubular epithelial cells in culture. Meprin merely delay the onset of renal failure as shown by the
A, extracted and purified from rats, was added to strains continued protection at 72 hours and 6 days.
of proximal tubular epithelial cells (LLC-PK1) and distal Taken together, the data presented strongly support
tubular epithelial cells (MDCK). Meprin led to both a the concept that meprin is directly cytotoxic to renal
concentration and time dependent increase in cell death epithelial cells. In addition, we provide the first direct
as measured by Trypan Blue exclusion, LDH release cause and effect evidence for the role of meprin in renal
and the MTT assay in both proximal and distal tubular hypoxia-reoxygenation and ischemia-reperfusion injury.
epithelial cells tested. A potent inhibitor of meprin, 1,10-
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